Cover image of Fabry guidelines


Life Saving Drugs Program – Fabry disease – Guidelines

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date: 
7 October 2020
Last updated: 
3 February 2021
Publication type: 
Intended audience: 
Health sector

These guidelines include:

  • General information about the Life Saving Drugs Program (LSDP)
  • Treatment of Fabry disease through the LSDP
  • Drugs currently available for the treatment of Fabry disease through the LSDP
  • Choice of treatment
  • Dosage
  • Home infusion
  • General, initial and ongoing eligibility requirements
  • LSDP funding conditions
  • Exclusion criteria.